Washington University
St. Louis, Missouri, United States
Purpose
To evaluate the ability of minibinders to alter type I and III interferon pathways in neonatal mice and improve immune response of oral vaccines for diseases that disproportionately impact low and middle income countries.
Division
Global Health
Date
July 2026
Region Served
GLOBAL
Committed amount
$554,535
Grant topic
Discovery and Translational Sciences, Enterics, Diagnostics, Genomics & Epidemiology
Duration (months)
18
Grantee location
St. Louis, Missouri, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.